- ISIN
- US2536511031
- CUSIP
- 253651103
- Sector
- Technology
- Industry
- Software - Application
Highlights
- Market Cap
- $2.96B
- Enterprise Value
- $3.52B
- EPS (TTM)
- $2.98
- PE Ratio
- 27.79
- PEG Ratio
- 0.07
- Total Revenue (TTM)
- $3.86B
- Gross Profit (TTM)
- $994.70M
- EBITDA (TTM)
- $366.00M
- Year Range
- $52.89 - $89.05
- Target Price
- $100.00
- ROA (TTM)
- 2.86%
- ROE (TTM)
- 10.71%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
DBD Performance Chart
Diebold Nixdorf, Incorporated (DBD) is up 22.1% since the beginning of the year. At $83 per share, DBD is trading 6.9% below its 52-week high of $89.
Loading charts...
Returns By Period
Diebold Nixdorf, Incorporated (DBD) has returned 22.08% so far this year and 60.06% over the past 12 months.
Diebold Nixdorf, Incorporated
- 1D
- -1.11%
- 1M
- 11.55%
- YTD
- 22.08%
- 6M
- 21.79%
- 1Y
- 60.06%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
DBD Monthly Returns History
Based on dividend-adjusted daily data since Aug 15, 2023, DBD's average daily return is +0.23%, while the average monthly return is +4.64%. At this rate, an investment would double in approximately 1.3 years.
Historically, 74% of months were positive and 26% were negative. The best month was May 2024 with a return of +38.2%, while the worst month was Jun 2024 at -12.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 2 months.
On a daily basis, DBD closed higher 53% of trading days. The best single day was Nov 5, 2025 with a return of +12.5%, while the worst single day was Nov 7, 2024 at -13.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.65% | 15.93% | -5.70% | 1.82% | 5.64% | 2.14% | 22.08% | ||||||
| 2025 | 0.58% | 2.17% | -1.15% | 1.40% | 8.66% | 15.01% | 1.61% | 8.56% | -6.68% | 3.72% | 9.08% | 5.22% | 57.74% |
| 2024 | 5.01% | 8.42% | 4.49% | -8.07% | 38.19% | -12.05% | 13.18% | 2.92% | -0.36% | 3.63% | -0.13% | -6.88% | 48.67% |
| 2023 | -10.05% | 6.34% | 0.21% | 35.30% | 12.73% | 46.21% |
Benchmark Metrics
Diebold Nixdorf, Incorporated has an annualized alpha of 45.84%, beta of 1.09, and R2 of 0.17 versus S&P 500 Index. Calculated based on daily prices since August 15, 2023.
- This stock captured 183.31% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -51.99%) - a profile typical of hedging or uncorrelated assets.
- R2 of 0.17 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 45.84%
- Beta
- 1.09
- R²
- 0.17
- Upside Capture
- 183.31%
- Downside Capture
- -51.99%
Return for Risk
Risk / Return Rank
DBD ranks 83 for risk / return — in the top 83% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Diebold Nixdorf, Incorporated (DBD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DBD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.31 | ||
| Sortino ratioReturn per unit of downside risk | -0.36 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.37 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 2.68 | 2.78 | -0.11 |
| Martin ratioReturn relative to average drawdown | 8.53 | 12.44 | -3.91 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Diebold Nixdorf, Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Diebold Nixdorf, Incorporated was 25.76%, occurring on Apr 8, 2025. Recovery took 41 trading sessions.
The current Diebold Nixdorf, Incorporated drawdown is 6.64%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -25.76%Apr 2025 | 5mo 2d | 1mo 29d | 7mo 1dNov 2024 - Jun 2025 |
2026 bear market2026 | -22.53%May 2026 | 29d | — | 2mo 4dApr 2026 - now |
2024 bear market2024 | -20.65%Jun 2024 | 28d | 2mo 6d | 3mo 4dMay 2024 - Aug 2024 |
2023 bear market2023 | -20.56%Sep 2023 | 22d | 2mo 7d | 2mo 29dAug 2023 - Nov 2023 |
2026 correction2026 | -13.97%Mar 2026 | 21d | 20d | 1mo 11dFeb 2026 - Apr 2026 |
Drawdown Indicators
| DBD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.76% | -56.78% | +31.02% |
Max Drawdown (1Y)Largest decline over 1 year | -22.53% | -9.10% | -13.43% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -6.64% | -1.80% | -4.84% |
Average DrawdownAverage peak-to-trough decline | -6.61% | -10.71% | +4.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.07% | 2.03% | +5.04% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Diebold Nixdorf, Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Diebold Nixdorf, Incorporated is priced in the market compared to other companies in the Software - Application industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DBD, comparing it with other companies in the Software - Application industry. Currently, DBD has a P/E ratio of 27.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DBD compared to other companies in the Software - Application industry. DBD currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DBD relative to other companies in the Software - Application industry. Currently, DBD has a P/S ratio of 0.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DBD in comparison with other companies in the Software - Application industry. Currently, DBD has a P/B value of 2.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with DBD
Add Diebold Nixdorf, Incorporated to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with DBD